AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Consolidation, lawsuits: mail-order Rx numbers may be on the rise.(Practice Trends)

OB GYN News

| April 15, 2004 | Frieden, Joyce | COPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The recent consolidation among pharmaceutical benefit managers may mean more mail-order prescriptions in physicians' futures, several experts said.

"Doctors will clearly notice they're writing prescriptions for longer duration, which is indicative of mail order," said Sean Brandle, a vice president at Segal Co., a New York consulting firm. "There are deeper discounts offered by [pharmaceutical benefit managers (PBMs)] for mail order versus [buying] retail."

The PBM world moved a bit closer to consolidation last fall, when Caremark, a Nashville-based company with approximately 25 million subscribers, agreed to buy Irving, Tex.-based AdvancePCS, with about 70 million subscribers, for $6 billion. This transaction, if approved by the Federal Trade Commission, will reduce the number of major PBMs from four to three. The Caremark deal was preceded by the Merck & Co. announcement in late August that it was spinning off its Franklin Lakes, N.J.--based Medco Health Solutions PBM subsidiary.

According to Caremark, the merger with AdvancePCS will "join together two highly complementary organizations in the competitive business of providing pharmaceutical and health improvement services to both the public and private sectors."

Pharmacist groups don't see the merger in such a positive light.

Even before the merger announcement, the National Community Pharmacists Association (NCPA) and the Pharmacy Freedom Fund (a coalition of independent pharmacy owners) sued Medco and AdvancePCS in federal court, alleging that the PBMs "have illegally reduced or eliminated competition on price, service, and consumer choice," according to an NCPA statement. Added John Rector, NCPA's senior vice president for government affairs, "There is virtually no competition among big PBMs. They have a renewal rate of about 96%, virtually no client turnover, and 3- to 5-year contracts."

The association opposes the Caremark-AdvancePCS merger.

Related articles from newspapers, magazines, journals, and more
FTC eyes role of PBMs in Medicare drug benefit.(Government)(Federal Trade...
Magazine article from: Chain Drug Review May 24, 2004 700+ words
...benefits management companies (PBMs) have a conflict of interest...pharmacies is the focus of a Federal Trade Commission study. PBMs are expected to be a key mechanism...have frequently criticized PBMs. Those pharmacies, particularly...
Setting the Record Straight on PBMs.
Press release article from: PR Newswire July 25, 2002 700+ words
...prescription drug costs. * PBMs are already regulated...up costs. Services that PBMs perform are regulated by...boards of pharmacy, the Federal Trade Commission, and the U.S. Department of Labor. * PBMs encourage use of less costly...
Pharmacy benefit management companies: federal regulation of PBMs is unlikely,...
Magazine article from: OB GYN News Silverman, Jennifer July 15, 2004 700+ words
...consulting, and other payments to PBMs." According to Mr. McCann...financial relationships with PBMs, "I think there are many people...prescription drug law calls on the Federal Trade Commission to look at whether...of inquiry that may relate to PBMs," Mr. McCann said. The story...
PBMs, chains work to improve relationship,.
Magazine article from: Chain Drug Review April 27, 1998 700+ words
...the questionable activities of PBMs affiliated with pharmaceutical...the playing field by forming PBMs of their own and/or by getting...year after learning that the Federal Trade Commission had closed its probe...collectively. One reason that PBMs and other managed care providers...
FTC asked to reexamine drug company-owned PBMs. (pharmacy benefits management)
Magazine article from: Chain Drug Review Monks, Richard January 20, 1997 700+ words
...met with the chairman of the Federal Trade Commission (FTC) to urge the...benefits management companies (PBMs) operate. In their talks with...between pharmaceutical makers and PBMs are causing prescription prices...mergers of drug suppliers and PBMs. "We felt that the FTC was...
Study eyes PBMs and dispensing of Generics.(Focus)(pharmacy benefits management)
Magazine article from: Chain Drug Review August 30, 2004 700+ words
...Modernization Act instructs the Federal Trade Commission to conduct a study...national association representing PBMs. "These findings serve to...months of last year by five large PBMs. The Harvard study adjusted...generic dispensing rate; for PBMs the rate is 39%. This rate...
PBMs: can't live with 'em, can't live without 'em. (pharmacy benefit...
Magazine article from: Medical Marketing & Media Gray, Michael September 1, 1995 700+ words
...study has revealed dissatisfaction with PBMs from a remarkably wide range of their consumers...has broadened the nature and functions of PBMs. It is still too early to assess the impact of the purchase of PBMs by large drug companies. In the constantly...
PBMs get new role; Seen as key to drug cost control under new benefit.(ABCDs of...
Magazine article from: Modern Healthcare Becker, Cinda December 22, 2003 700+ words
...bearing, direct-to-consumer businesses. PBMs manage the prescription drug benefits for...radar screens of consumers. Four national PBMs-AdvancePCS, Caremark Rx, Express Scripts...in September announced plans to merge. PBMs manage about two-thirds of the nation...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA